UK obesity campaign risked turning fat-shaming into political strategy
The national obesity campaign launched by the UK government to improve health and protect the NHS during the COVID-19 pandemic was...
Browse by category
Search
Obesity and stress influence appetite triggered by reward and cognitive control influences
In a series of experiments using functional magnetic resonance imaging (fMRI) to measure brain activity across networks in the brain,...
Mazdutide anti-obesity drug achieves 11.7% body weight loss at 12-weeks
Innovent Biologics has announced that the results of a phase 1b study of mazdutide (IBI362), a glucagon-like peptide-1 (GLP-1) and...
UK launches first digital support tool for NHS Tier 3 Weight Management Services to tackle obesity
W8Buddy (WeightBuddy), a new digital support tool that can help patients achieve clinically meaningful weight loss has been launched by...
Report finds Australians fail to consider the complex causes of obesity
Simplistic stereotypes of Australians living with obesity blame the individual and fail to consider the complex causes, according to a...
UEG report reveals major health and economic impacts of digestive diseases across Europe
Data from a pan-European study on the burden of digestive diseases, presented today at United European Gastroenterology Week 2022 and...
Journal Watch 12/10/2022
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Bariatric surgery associated with significant reduction in CVD risk in patients with severe obesity
Researchers from the Ohio State University, Columbus, OH, have report that bariatric surgery, compared with nonsurgical care, was...
Prevalence of obesity varies significantly among Asian American subgroups
A cross-sectional study of more than 70,000 Asian Americans has found that the prevalence of obesity in Asian American subgroups varies...
Sciwind begins clinical trial of XW014 for Obesity and T2DM
Sciwind Biosciences has initiated of dosing in a Phase 1 clinical trial evaluating XW014, a novel oral small molecule glucagon-like...
